207 related articles for article (PubMed ID: 21780551)
21. [Effect of probiotic Saccharomyces boulardii on prevention of antibiotic-associated diarrhea in adult outpatients with amoxicillin treatment].
Bravo MV; Bunout D; Leiva L; de la Maza MP; Barrera G; de la Maza J; Hirsch S
Rev Med Chil; 2008 Aug; 136(8):981-8. PubMed ID: 18949181
[TBL] [Abstract][Full Text] [Related]
22. [Natural therapy instead of chemistry? Probiotics in gastroenterology].
Kirchgatterer A; Knoflach P
Acta Med Austriaca; 2004 Feb; 31(1):13-7. PubMed ID: 15259592
[TBL] [Abstract][Full Text] [Related]
23. Probiotics and gastrointestinal conditions: An overview of evidence from the Cochrane Collaboration.
Parker EA; Roy T; D'Adamo CR; Wieland LS
Nutrition; 2018 Jan; 45():125-134.e11. PubMed ID: 28870406
[TBL] [Abstract][Full Text] [Related]
24. Probiotic Saccharomyces cerevisiae strains as biotherapeutic tools: is there room for improvement?
Palma ML; Zamith-Miranda D; Martins FS; Bozza FA; Nimrichter L; Montero-Lomeli M; Marques ET; Douradinha B
Appl Microbiol Biotechnol; 2015 Aug; 99(16):6563-70. PubMed ID: 26142388
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and safety of Saccharomyces boulardii in the 14-day triple anti-Helicobacter pylori therapy: a prospective randomized placebo-controlled double-blind study.
Cindoruk M; Erkan G; Karakan T; Dursun A; Unal S
Helicobacter; 2007 Aug; 12(4):309-16. PubMed ID: 17669103
[TBL] [Abstract][Full Text] [Related]
26. Saccharomyces boulardii in acute childhood diarrhoea: a randomized, placebo-controlled study.
Villarruel G; Rubio DM; Lopez F; Cintioni J; Gurevech R; Romero G; Vandenplas Y
Acta Paediatr; 2007 Apr; 96(4):538-41. PubMed ID: 17306006
[TBL] [Abstract][Full Text] [Related]
27. Probiotics in primary care pediatrics.
Cabana MD; Shane AL; Chao C; Oliva-Hemker M
Clin Pediatr (Phila); 2006 Jun; 45(5):405-10. PubMed ID: 16891272
[TBL] [Abstract][Full Text] [Related]
28. Molecular tools for differentiating probiotic and clinical strains of Saccharomyces cerevisiae.
Posteraro B; Sanguinetti M; Romano L; Torelli R; Novarese L; Fadda G
Int J Food Microbiol; 2005 Sep; 103(3):295-304. PubMed ID: 16099314
[TBL] [Abstract][Full Text] [Related]
29. Molecular analysis of the digestive microbiota in a gnotobiotic mouse model during antibiotic treatment: Influence of Saccharomyces boulardii.
Barc MC; Charrin-Sarnel C; Rochet V; Bourlioux F; Sandré C; Boureau H; Doré J; Collignon A
Anaerobe; 2008 Oct; 14(4):229-33. PubMed ID: 18511310
[TBL] [Abstract][Full Text] [Related]
30. Use of probiotics in various diseases: evidence and promises.
Tanriover MD; Aksoy DY; Unal S
Pol Arch Med Wewn; 2012; 122 Suppl 1():72-7. PubMed ID: 23222204
[TBL] [Abstract][Full Text] [Related]
31. Role of yeasts in healthy and impaired gut microbiota: the gut mycome.
Ianiro G; Bruno G; Lopetuso L; Beghella FB; Laterza L; D'Aversa F; Gigante G; Cammarota G; Gasbarrini A
Curr Pharm Des; 2014; 20(28):4565-9. PubMed ID: 24180411
[TBL] [Abstract][Full Text] [Related]
32. Probiotics for children with diarrhea: an update.
Guandalini S
J Clin Gastroenterol; 2008 Jul; 42 Suppl 2():S53-7. PubMed ID: 18520336
[TBL] [Abstract][Full Text] [Related]
33. Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea in children: a randomized double-blind placebo-controlled trial.
Kotowska M; Albrecht P; Szajewska H
Aliment Pharmacol Ther; 2005 Mar; 21(5):583-90. PubMed ID: 15740542
[TBL] [Abstract][Full Text] [Related]
34. Functional heterologous protein expression by genetically engineered probiotic yeast Saccharomyces boulardii.
Hudson LE; Fasken MB; McDermott CD; McBride SM; Kuiper EG; Guiliano DB; Corbett AH; Lamb TJ
PLoS One; 2014; 9(11):e112660. PubMed ID: 25391025
[TBL] [Abstract][Full Text] [Related]
35. Use of complementary and alternative medicine by pediatric patients with functional and organic gastrointestinal diseases: results from a multicenter survey.
Vlieger AM; Blink M; Tromp E; Benninga MA
Pediatrics; 2008 Aug; 122(2):e446-51. PubMed ID: 18662934
[TBL] [Abstract][Full Text] [Related]
36. Clinical use of probiotics in the pediatric population.
Wallace B
Nutr Clin Pract; 2009; 24(1):50-9. PubMed ID: 19244149
[TBL] [Abstract][Full Text] [Related]
37. Lactic acid bacteria as probiotics.
Ljungh A; Wadström T
Curr Issues Intest Microbiol; 2006 Sep; 7(2):73-89. PubMed ID: 16875422
[TBL] [Abstract][Full Text] [Related]
38. Safety of probiotics.
Donohue DC
Asia Pac J Clin Nutr; 2006; 15(4):563-9. PubMed ID: 17077077
[TBL] [Abstract][Full Text] [Related]
39. Interaction of Saccharomyces boulardii with intestinal brush border membranes: key to probiotic effects?
Buts JP; De Keyser N
J Pediatr Gastroenterol Nutr; 2010 Oct; 51(4):532-3. PubMed ID: 20706146
[TBL] [Abstract][Full Text] [Related]
40. The probiotic paradox: live and dead cells are biological response modifiers.
Adams CA
Nutr Res Rev; 2010 Jun; 23(1):37-46. PubMed ID: 20403231
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
